1. Hutchinson J: The crateriform ulcer of the face: A form of acute epithelial cancer. Trans Pathol Soc London 40:275, 1889
2. Rook A, Whimster I: Le Kerato-Acanthome. Arch Belg Dermatol Syphiligr 6:137, 1950
3. Ferguson-Smith J: A case of multiple primary squamous celled carcinomata of the skin in a young man, with spontaneous healing. Br J Dermatol Syph 46:267, 1934
4. Grzybowski MA: A case of peculiar generalized epithelial tumours of the skin. Br J Dermatol Syphiligr 62:310, 1950
5. Fisher AA: A distinctive destructive digital disease. Arch Dermatol 83:1030, 1961
6. Miedzinski F, Kozakiewicz J: Das Keratoakanthoma centrifugum—Eine besondere Varietät des Keratoakanthoms. Hautarzt 13:348, 1962
7. Puente Duany N: Squamous cell pseudoepithelioma (keratoacanthoma): A new clinical variety, gigantic, multiple, and localized. Arch Dermatol 91:505, 1958
8. Kumar V et al: Multiple keratoacanthoma with neonatal onset in a girl. Pediatr Dermatol 16:411, 1999
9. Chuang TY et al: Keratoacanthoma in Kauai, Hawaii. The first documented incidence in a defined population. Arch Dermatol 129:317, 1993
10. Kwittken JA: A histologic chronology of the clinical course of the keratocarcinoma (so-called keratoacanthoma). Mt Sinai J Med 42:127, 1975
11. Rook A, Whimster I: Keratoacanthoma: A thirty-year retrospect. Br J Dermatol 100:41, 1979
12. Hodak E, Jones RE, Ackerman AB: Solitary keratoacanthoma is a squamous-cell carcinoma: Three examples with metastases. Am J Dermatopathol 15:332, 1993
13. Goldenhersh MA, Olsen TG: Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma. J Am Acad Dermatol 10:372, 1984
14. Godbolt AM, Sullivan JJ, Weedon D: Keratoacanthoma with perineural invasion: A report of 40 cases. Australas J Dermatol 42:168, 2001
15. Choonhakarn C, Ackerman AB: Keratoacanthomas: A new classification based on morphologic findings and on anatomic site. Dermatopathol Pract Concept 7:7, 2001
16. Sanchez-Yus E et al: Solitary keratoacanthoma: A self-healing proliferation that frequently becomes malignant. Am J Dermatopathol 22:305, 2000
17. Cribier B, Asch PH, Grosshans E: Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 199:208, 1999
18. Esser
AC et al: Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with
infliximab.
J Am Acad Dermatol 50(5 Suppl):s75, 2004
19. Skalova A, Michal M: Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin: Immunohistochemical study using the MIB-1 antibody in formalin-fixed paraffin sectiuons. Am J Dermatopathol 17:332, 1995
20. Cheville JC, Bromley C, Argenyi ZB: Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in situ hybridization. J Cutan Pathol 22:546, 1995
21. Perez MI et al: p53 oncoprotein expression and gene mutations in some keratoacanthomas. Arch Dermatol 133:189, 1997
22. Tran TA et al: Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma. Mod Pathol 13:427, 2000
23. Tran TA et al: Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma. J Cutan Pathol 26:391, 1999
24. Kaabipour E et al: p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: An immunohistochemical study. Arch Pathol Lab Med 130:69, 2006
25. Kerschmann RL, McCalmont TH, LeBoit PE: P53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 130:181, 1994
26. Waring AJ et al: Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 73:649, 1996
27. Takeda H, Kondo S: Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 158:1633, 2001
28. Krunic AL et al: Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: Actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 77:1275, 1998
29. Clausen OP et al: Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol 119:1367, 2002
30. Clausen OP et al: Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. Br J Dermatol 126:2308, 2006
31. Melendez ND, Smoller BR, Morgan M: VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol 16:8, 2003
32. Putti
TC, Teh M, Lee YS: Biological behavior of keratoacanthoma and squamous cell carcinoma: Telomerase activity and COX-2 as potential markers.
Mod Pathol 17:468, 2004
33. Slater M, Barden JA: Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology 47:170, 2005
34. Ashton KJ, Carless MA, Griffiths LR: Cytogenetic alterations in nonmelanoma skin cancer: A review. Genes Chromosomes Cancer 43:239, 2005
35. Schwartz RA: Keratoacanthoma: A clinico-pathologic enigma. Dermatol Surg 30:326, 2004
36. Penmetcha M, Highet AS, Hopkinson JM: Failure of PUVA in lichen myxedematosus: Acceleration of associated multiple keratoacanthomas with development of squamous carcinoma. Clin Exp Dermatol 12:220, 1987
37. Henseler T et al: Skin tumors in the European PUVA study. Eight-year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 16:108, 1987
38. Ghadially FN, Barton BW, Kerridge DF: The etiology of keratoacanthoma. Cancer 16:603, 1963
39. Schwartz RA: Keratoacanthoma. J Am Acad Dermatol 30:1, 1994
40. Ghadially FN: The role of the hair follicle in the origin and evolution of some cutaneous neoplasms of man and experimental animals. Cancer 14:801, 1961
41. Pattee SF, Silvis NG: Keratoacanthoma developing in sites of previous trauma: A report of two cases and review of the literature. J Am Acad Dermatol 48(2 Suppl):s35, 2003
42. Fraga GR, Prossick TA: Tattoo-associated keratoacanthomas: A series of 8 patients with 11 keratoacanthomas. J Cut Pathol 37:85, 2010
43. Hsi ED et al: Detection of human papillomavirus DNA in keratoacanthomas by polymerase chain reaction. Am J Dermatopathol 19:10, 1997
44. Forslund O et al: Identification of human papillomavirus in keratoacanthomas. J Cutan Pathol 30:423, 2003
45. Lu S et al: Known HPV types have no association with keratoacanthomas. Arch Dermatol Res 288:129, 1996
46. Payne D, Newman C, Tyring S: Human papillomavirus DNA in nonanogenital keratoacanthoma and squamous cell carcinoma of patients with HIV infection. J Am Acad Dermatol 33:1047, 1995
47. Gassenmaier A, Pfister H, Hornstein OP: Human papillomavirus 25-related DNA in solitary keratoacanthoma. Arch Dermatol Res 279:73, 1986
48. Honchel R et al: Microsatellite instability in Muir-Torre syndrome. Cancer Res 54:1159, 1994
49. Burgdorf WH, Pitha J, Fahmy A: Muir-Torre syndrome. Histologic spectrum of sebaceous proliferations. Am J Dermatopathol 8:202, 1986
50. Ponti G et al: Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: Role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 103:1018, 2005
51. Ponti G et al: Different phenotypes in Muir-Torre syndrome: Clinical and biomolecular characterization in two Italian families. Br J Dermatol 152:1335, 2005
52. Stoebner PE et al: Solitary subungual keratoacanthoma arising in an MSH2 germline mutation carrier: Confirmation of a relationship by immunohistochemical analysis. Dermatology 219:174, 2009
53. Stockfleth E et al: Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients. Dermatology 198:122, 1999
54. Ridd K, Vemula S, Bastian BC: Absence of somatic mutations of NEMO in keratoacanthoma. J Invest Dermatol 129:2518, 2009
55. Ferguson-Smith MA et al: Multiple self-healing squamous epithelioma. Birth Defects 7:157, 1971
56. Schaller M et al: Multiple keratoacanthomas, giant keratoacanthoma and keratoacanthoma centrifugum marginatum: Development in a single patient and treatment with oral
isotretinoin.
Acta Derm Venereol 76:40, 1996
57. Divers AK, Correale D, Lee JB: Keratoacanthoma centrifugum marginatum: A diagnostic and therapeutic challenge. Cutis 73:257, 2004
58. Baran R, Goettmann S: Distal digital keratoacanthoma: A report of 12 cases and a review of the literature. Br J Dermatol 139:512, 1998
59. Karaa A, Khachemoune A: Keratoacanthoma: A tumor in search of a classification. Int J Dermatol 46:671, 2007
60. Kingman J, Callen JP: Keratoacanthoma: A clinical study. Arch Dermatol 120:736, 1984
61. Larson PO: Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery). A review of forty-three cases. J Am Acad Dermatol 16:1040, 1987
62. Donahue B, Cooper JS, Rush S: Treatment of aggressive keratoacanthomas by radiotherapy. J Am Acad Dermatol 23:489, 1990
63. Melton JL et al: Treatment of keratoacanthomas with intralesional
methotrexate.
J Am Acad Dermatol 25:1017, 1991
64. Yuge S et al: Keratoacanthoma centrifugum marginatum: Response to topical 5-fluorouracil. J Am Acad Dermatol 54:s218, 2006
65. Somlai B, Hollo P: Die Anwendung von Interferon alpha (IFN alpha) in der Keratoakanthombehandlung. Hautarzt 51:173, 2000
66. Oh CK et al: Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol 51(5 Suppl):s177, 2004. Erratum in: J Am Acad Dermatol 51:1040, 2004
67. Street ML, White JW Jr, Gibson LE: Multiple keratoacanthomas treated with oral retinoids. J Am Acad Dermatol 23:862, 1990
68. Calzavara-Pinton PG: Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 29:53, 1995
69. Radakovic-Fijan S, Hönigsmann H, Tanew A: Efficacy of topical photodynamic therapy of a giant keratoacanthoma demonstrated by partial irradiation. Br J Dermatol 141:936, 1999
70. Di Lernia V, Ricci C, Albertini G: Spontaneous regression of keratoacanthoma can be promoted by topical treatment with
imiquimod cream.
J Eur Acad Dermatol Venereol 18:626, 2004
71. Bulj TK et al: Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with epidermal growth factor receptor inhibitor
erlotinib.
Br J Dermatol 163(3):633-7, 2010 Mar 6. [Epub ahead of print]